Table 7.
Reliable change index.
| PP1 | PP2 | PP3 | PP4 | |
|---|---|---|---|---|
| HADS-D | ||||
| Pre-baseline | 7 | 9 | 9 | 5 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 6 (0.40) | 11 (−0.80) | 9 (0) | 9 (−1.61) |
| During-treatment (RCI pre-treatment/During-treatment) | 5 (0.40) | 3 (3.21*) | 8 (0.40) | 6 (1.21) |
| Post-treatment (RCI pre-treatment/post-treatment) | 2 (1.61) | 7 (1.61) | 5 (1.61) | 3 (2.41*) |
| 7 month FU (RCI pre-treatment/7FU) | 1 (2.01*) | 3 (3.22*) | 11 (−0.80) | 3 (2.41*) |
| 12 months FU (RCI pre-treatment/12FU) | 0 (2.41*) | 3 (3.22*) | 10 (−0.40) | 0 (3.62*) |
| HADS-A | ||||
| Pre-baseline | 10 | 3 | 6 | 7 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 10 (0) | 16 (−5.66) | 8 (−0.87) | 8 (−0.43) |
| During-treatment (RCI pre-treatment/During-treatment) | 10 (0) | 6 (4.35*) | 7 (0.44) | 6 (0.87) |
| Post-treatment (RCI pre-treatment/post-treatment) | 4 (2.61*) | 8 (3.48*) | 3 (2.17*) | 5 (1.31) |
| 7 month FU (RCI pre-treatment/7FU) | 2 (3.48*) | 4 (5.22*) | 7 (0.43) | 5 (1.31) |
| 12 months FU (RCI pre-treatment/12FU) | 0 (4.35*) | 6 (4.35*) | 10 (−0.87) | 5 (1.31) |
| DASS-21 stress | ||||
| Pre-baseline | 15 | 9 | 12 | 5 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 11 (1.65) | 18 (−3.72) | 11 (0.41) | 6 (−0.41) |
| During-treatment (RCI pre-treatment/During-treatment) | 12 (−0.41) | 5 (5.37*) | 9 (0.83) | 6 (0) |
| Post-treatment (RCI pre-treatment/post-treatment) | 5 (2.48*) | 6 (4.96*) | 6 (2.07*) | 5 (0.41) |
| 7 month FU (RCI pre-treatment/7FU) | 3 (3.31*) | 5 (5.37*) | 8 (1.24) | 4 (0.83) |
| 12 months FU (RCI pre-treatment/12FU) | 0 (4.54*) | 4 (5.78*) | 10 (0.41) | 4 (0.83) |
| AAQ-II | ||||
| Pre-baseline | 15 | 15 | 14 | 9 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 12 (0.66) | 34 (−4.17) | 11 (0.66) | 11 (−0.44) |
| During-treatment (RCI pre-treatment/During-treatment) | 15 (−0.66) | 17 (3.73*) | 12 (−0.22) | 10 (0.22) |
| Post-treatment (RCI pre-treatment/post-treatment) | 9 (0.66) | 7 (5.93*) | 9 (0.44) | 9 (0.44) |
| 7 month FU (RCI pre-treatment/7FU) | 8 (0.88) | 14 (4.39*) | 16 (−1.09) | 8 (0.66) |
| 12 months FU (RCI pre-treatment/12FU) | 8 (0.88) | 11 (5.05*) | 13 (−0.44) | 7 (0.88) |
| AAQ-ABI | ||||
| Pre-baseline | 12 | 7 | 8 | 9 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 7 (1.20) | 27 (−4.80) | 10 (−0.48) | 9 (0) |
| During-treatment (RCI pre-treatment/During-treatment) | 12 (−1.20) | 10 (4.08*) | 9 (0.24) | 7 (0.48) |
| Post-treatment (RCI pre-treatment/post-treatment) | 1 (1.44) | 11 (3.84*) | 7 (0.72) | 5 (0.96) |
| 7 month FU (RCI pre-treatment/7FU) | 2 (1.20) | 6 (5,04*) | – | 3 (1.44) |
| 12 months FU (RCI pre-treatment/12FU) | 1 (1.44) | 8 (4,56*) | 12 (−0.48) | 1 (1.92) |
| CFQ-7 | ||||
| Pre-baseline | 33 | 35 | 24 | 17 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 19 (3.61*) | 44 (−2.32) | 36 (−3.10) | 12 (1.28) |
| During-treatment (RCI pre-treatment/During-treatment) | 23 (−1.03) | 32 (3.10*) | 33 (0.77) | 11 (0.26) |
| Post-treatment (RCI pre-treatment/post-treatment) | 10 (2.32*) | 17 (6.97*) | 14 (5.68*) | 12 (0) |
| 7 month FU (RCI pre-treatment/7FU) | 7 (3.10*) | 11 (8.51*) | 26 (2.58*) | 10 (0.52) |
| 12 months FU (RCI pre-treatment/12FU) | 10 (2.32*) | 20 (6.19*) | 24 (3.10*) | 9 (0.77) |
| VLQ composite score | ||||
| Pre-baseline | – | 53.50 | – | 56.80 |
| Pre-treatment (RCI pre-baseline/pre-treatment | 45.20 | 52.00 (0.14) | 47.40 | 61.90 (−0.49) |
| During-treatment (RCI pre-treatment/During-treatment) | 55.90 (−1.02) | 48.20 (0.36) | 33.90 (1.29) | 53.20 (0.83) |
| Post-treatment (RCI pre-treatment/post-treatment) | – | 57.60 (−0.54) | 35.80 (1.11) | 58.90 (0.29) |
| 7 month FU (RCI pre-treatment/7FU) | 53.60 (−0.80) | 59.20 (−0.69) | 34.40 (1.25) | 66.70 (−0.46) |
| 12 months FU (RCI pre-treatment/12FU) | – | 53.50 | – | 56.80 |
Abbreviations: HADS: Hospital Anxiety and Depression Scale; DASS-21: Depression, anxiety and stress scale-21; AAQ-II: Acceptance and Action Questionnaire II; AAQ-ABI: Acceptance and Action Questionnaire after brain injury; VLQ: Valued Living Questionnaire; CFQ-7: Cognitive Fusion Questionnaire.
Note: Table includes raw scores with the reliable change index between brackets.
*Clinical significant change.